Can Merck resurrect its $200M Sovaldi patent judgment against Gilead at the Supreme Court? Merck ($MRK) lost a $200M patent judgment against Gilead ($GILD) after the Court found that Merck engaged in business and litigation misconduct. Merck is now appealing to the Supreme Court, asking to resurrect that judgment. Will it prevail? Read More Markman AdvisorsSeptember 28, 2018Merck, $MRK, Gilead, $GILD, Sovaldi, patent, Supreme Court, unclean hands, inequitable conduct, Zachary, Zachary Silbersher, SilbersherComment
